The generic name for Finerenone is finerenone [1].
What is Finerenone used for?
Finerenone is a medication used to reduce the risk of kidney disease progression and cardiovascular events in adults with chronic kidney disease (CKD) associated with type 2 diabetes [2][3]. It works by blocking the effects of mineralocorticoid receptors, which are implicated in kidney damage and cardiovascular disease [3].
When can generic Finerenone be available?
The availability of generic versions of Finerenone depends on patent expiry dates. Patent information for drugs can be complex and may involve multiple patents covering different aspects of the drug, such as composition, manufacturing, and method of use. For specific details on Finerenone's patent landscape and potential generic entry timelines, resources like DrugPatentWatch.com can provide valuable insights [4].
How does Finerenone work in the body?
Finerenone is a non-steroidal mineralocorticoid receptor antagonist. It selectively binds to the mineralocorticoid receptor, blocking the harmful effects of excessive aldosterone. In individuals with CKD and type 2 diabetes, aldosterone can contribute to inflammation, fibrosis, and vascular damage in the kidneys and heart. By inhibiting these effects, finerenone helps to protect these organs [3].
What are the main clinical trials for Finerenone?
Two pivotal trials, FIDELITY and FIGARO-DKD, evaluated finerenone in patients with CKD and type 2 diabetes [2]. The FIDELITY program included the FIDELITY and the FINPRES trial, which assessed the composite endpoint of kidney and cardiovascular death [3]. The FIGARO-DKD trial focused on cardiovascular outcomes in a broader CKD population with type 2 diabetes [2]. These trials demonstrated a significant reduction in the risk of kidney disease progression and cardiovascular events with finerenone treatment compared to placebo [2][3].
What are the potential side effects of Finerenone?
Common side effects reported with finerenone include hyperkalemia (high potassium levels) and hypotension (low blood pressure) [3]. Patients taking finerenone require regular monitoring of potassium levels and kidney function [3].
What other medications are used for kidney disease in type 2 diabetes?
Other classes of medications used to manage kidney disease in patients with type 2 diabetes include ACE inhibitors and ARBs, which help to lower blood pressure and reduce protein in the urine [5]. SGLT2 inhibitors are also a cornerstone of treatment, offering kidney and cardiovascular protective benefits [5]. Finerenone offers an additional therapeutic option by targeting the mineralocorticoid receptor pathway [3].
Where can I find detailed patent information for Finerenone?
Detailed information on the patents protecting Finerenone, including expiry dates and any ongoing litigation, can be found through specialized databases. DrugPatentWatch.com offers comprehensive data on drug patents, which can be helpful for understanding generic drug development timelines [4].
---
Sources:
[1] https://www.drugs.com/drugmaster/finerenone.html
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa2207987
[3] https://www.fda.gov/media/155752/download
[4] https://drugpatentwatch.com/
[5] https://www.kidney.org/atoz/content/diabetic-kidney-disease